Explore the groundbreaking work of the Quave Research Group at Emory University, where we’re pioneering new treatments for drug-resistant bacterial infections using medicinal plants. Our unique ethnobotanical approach to drug discovery involves studying traditional medical practices and the plants used in these remedies. We focus on disabling bacterial defense and offense mechanisms, making them more susceptible to antibiotic action. Our research has led to the development of an anti-biofilm and antivirulence agents and the founding of the biotech companies PhytoTEK LLC and Verdant Scientific Inc. Our mission is deeply personal, driven by Dr. Quave’s own experience with a life-threatening staphylococcal infection. We believe the solution to such infections may lie in medicinal plant products. Discover more about our research, funding sources, and how to support our mission on our website.